PerkinElmer (PKI)

$138.62 0.60 (0.43%)

9:35 EST PKI Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 15.34B

PE Ratio 105.02

EPS 1.32

Volume (Avg. Vol.) 5,638

Day's Range 138.30 - 138.62

52-Week Range 62.91 - 142.65

Dividend & Yield 0.28 (0.20%)

PKI Stock Predictions, Articles, and PerkinElmer News

From InvestorPlace
From the Web

The 10 Best Stocks to Buy for May

By James Brumley, InvestorPlace Feature Writer May 1, 2019

Expedia, Alexion and DowDuPont are just some of the stocks to buy to overcome the marketwide lethargy that takes shape this time of year.

7 Mid-Cap Stocks to Find the Market’s Sweet Spot

By Louis Navellier, Editor, Growth Investor Apr 12, 2019

As economic growth slows down, these slow-and-steady mid-cap stocks would make a great addition to your portfolio.

The 10 Most Expensive Stocks In The S&P 500

By Matt Hogan, Founder, Finbox.io Jan 24, 2018

These ten stocks are currently the most expensive stocks trading on the S&P 500 -- so buyer beware.

Earnings Momentum Make PerkinElmer (PKI) a Buy

By Portfolio Grader Dec 7, 2017

With a $8.1 billion market value, PerkinElmer Inc (NYSE:PKI) ranks in the top 25% of its industry group, Life Sciences Tools & Services, and in the top quarter of its sector group, Health Care, in market value. From the vantage point of investment attractiveness, Portfolio Grader's current ranking for PKI puts it 14 among the 31 companies in this industry group, putting it in the second quartile; in the top quartile of the sector with a ranking of 178 among the 782 companies in the sector, and number 956 in the nearly 5,000 company Portfolio Grader universe.

Earnings Growth Keep PerkinElmer (PKI) a Buy

By Portfolio Grader Nov 30, 2017

Currently, PerkinElmer Inc (NYSE:PKI) has a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. PKI has maintained this ranking for the last month.

PerkinElmer (PKI) a Buy on Healthy Earnings Growth

By Portfolio Grader Nov 23, 2017

PerkinElmer Inc (NYSE:PKI) is a constituent of the 32 company Life Sciences Tools & Services GICS industry group, which is part of the 781 company GICS Health Care sector. PKI has a market value of $8.0 billion which is in the top 25% of its industry group. Currently, the stock's Portfolio Grader ranking places it 7 among the 32 companies in this industry group, placing it among the leaders; in the top quartile of the sector with a ranking of 82 among the 781 companies in the sector, and number 512 in the nearly 5,000 company Portfolio Grader universe.

PerkinElmer’s (PKI) Healthy Quant Score Keep it a Buy

By Portfolio Grader Nov 16, 2017

The current recommendation of Buy for PerkinElmer Inc (NYSE:PKI) is the result of using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing system. This represents no change from the previous week and is the same ranking PKI has had from Portfolio Grader for the last month.

Earnings Momentum Keep PerkinElmer (PKI) a Buy

By Portfolio Grader Nov 9, 2017

PerkinElmer Inc (NYSE:PKI) is ranked as a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methods. PKI has maintained this ranking for the last month.

Quant Score Keeps PerkinElmer (PKI) a Buy

By Portfolio Grader Nov 2, 2017

Portfolio Grader currently ranks PerkinElmer Inc (NYSE:PKI) a Buy. With proprietary fundamental and quantitative metrics developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. PKI has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Strong Quant Score Keeps PerkinElmer (PKI) a Buy

By Portfolio Grader Oct 26, 2017

PerkinElmer Inc (NYSE:PKI) is ranked as a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. PKI has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

PerkinElmer (PKI) Upgraded to Buy on Superior Quant Score

By Portfolio Grader Oct 19, 2017

Currently, PerkinElmer Inc (NYSE:PKI) has a Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. PKI has been upgraded from a Hold to a Buy in the last week.

PerkinElmer (PKI) Upgraded to Buy from a Hold

By Portfolio Grader Oct 12, 2017

Currently, PerkinElmer Inc (NYSE:PKI) has a Buy using Louis Navellier's system for investing and his Portfolio Grader stock evaluator. The shares have been upgraded from a Hold to a Buy in the last week.